Velarion · Company Intelligence
CompBrief
Fiscal year 2025

Laura Niklason — FY2025 total compensation $5,234,908

Laura Niklason is President, Chief Executive Officer and Director of Humacyte, Inc. (HUMA). The company reported total compensation of $5,234,908 for fiscal year 2025.

01

Fiscal year 2025 compensation

Salary$633,606
Bonus$253,983
Stock awards$0
Option awards$4,332,725
Non-equity incentive plan$0
Pension and non-qualified deferred compensation$0
All other compensation$14,594
Total$5,234,908

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.

Cited to the compensation disclosure Humacyte, Inc. filed April 28, 2026, accession 0001193125-26-187449.

02

History — every fiscal year held

Fiscal yearRoleSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
FY2025President, Chief Executive Officer and Director$633,606$253,983$0$4,332,725$0$0$14,594$5,234,908
FY2024President, Chief Executive Officer and Director$612,400$278,642$0$0$0$0$14,394$905,436

Totals as disclosed in each year's own compensation disclosure for Humacyte, Inc..

03

Peer context

Peer-group chief executive median$5,647,797
Difference from that median$-412,888
Percentile within the disclosed peer group50th
Peers with a disclosed figure11

Medians and percentiles are computed across the peer group Humacyte, Inc. discloses in its own compensation disclosure.

04

The other named executive officers of Humacyte, Inc.

Named executive officerRoleFY2025 total
Laura Niklason this pagePresident, Chief Executive Officer and Director$5,234,908
Dale SanderChief Financial Officer, Chief Corporate Development Officer and Treasurer$2,131,658
Shamik ParikhChief Medical Officer$2,096,556

The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Humacyte, Inc. compensation brief.

05

The company page

Laura Niklason's compensation sits inside Humacyte, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.

The Humacyte, Inc. (HUMA) compensation brief